Skip to content
EvidenceBased
SavedSign in
Skip to content
EvidenceBased
interventions / Berberine / inflammation

Does Berberine help inflammation? (Grade B evidence)

Explore current source-reported research for this exact question. These records are separate from the synthesis below; they do not update its grade or establish a recommendation.

Berberine shows a Grade B benefit for inflammation — moderate-certainty evidence in the recorded sources, especially in adults, especially with cardiovascular disease or diabetes. Typical studied doses are varies across trials.

Exact question reviewed

Population
adults, especially with cardiovascular disease or diabetes
Intervention
Berberine · varies across trials
Comparator
not reported
Outcome
inflammation
Time horizon
not reported

Bottom line. Berberine shows a Grade B benefit for inflammation — moderate-certainty evidence in the recorded sources, especially in adults, especially with cardiovascular disease or diabetes. Typical studied doses are varies across trials. [1 SR/meta]

Direction
benefit
Magnitude
Meta-analysis of 5 RCTs: berberine supplementation significantly decreased serum C-reactive protein versus control, with no significant heterogeneity between studies. The authors note patients with cardiovascular disease and diabetes may be the groups most likely to benefit; larger confirmatory trials are still needed.
Grade
B
Certainty
moderate
Clinical meaning
small but potentially useful
Who it applies to
adults, especially with cardiovascular disease or diabetes
Dose / form studied
varies across trials
Safety
moderate_with_metformin
The one limitation
Claim-specific limitation details are not available in this public record.

Reviewed not reported · Evidence last changed · Open evidence record (version 0)

⚠ Safety in context

Grade
B
what does the grade mean?
Certainty
moderate
what does certainty mean?

Grade B / moderate: probably helps, and new studies are unlikely to reverse this — but could shrink the effect size.

Who it works for

Best-studied in adults, especially with cardiovascular disease or diabetes. Recorded studied dose: varies across trials.

Evidence

StudyDesignRoleCite
Effect of Berberine on C-reactive protein: A systematic review and meta-analysis of randomized controlled trials.peer-reviewedsupportsPMID:31519292

Why this grade

Reasoning trace

The current record stores Grade B at moderate certainty and links 1 publishable source. A claim-specific domain-by-domain grading rationale is not available in this public record, so no reason for upgrading or downgrading is inferred here.

Audit and version

Claim ID
ec_b11-berberine-inflammation
Claim version
not reported
Governance
legacy, not verified
Clinician review
Not yet reviewed by a licensed clinician
Last evidence search
not reported
Last editorial review
not verified

Public receipt · Machine-readable claim · Methodology

Dose & form

Studied intake: varies across trials.

How it stacks up for inflammation

Grade history

No grade changes yet. Initial grade assigned; re-reviewed on every 12 months (Grade A/B). Methodology v1.

Re-review cadence: every 12 months (Grade A/B) · methodology v1.

Frequently asked

How long does Berberine take to work for inflammation?

This record does not report a studied onset time for Berberine and inflammation. Do not assume a typical timeframe.

What dose was used in studies of Berberine for inflammation?

The recorded studied dose for Berberine and inflammation is varies across trials. This is a source detail, not a dose recommendation.

Does Berberine work for inflammation if I'm not deficient?

The recorded studied population is adults, especially with cardiovascular disease or diabetes. This field alone does not show whether deficiency or baseline status changes the effect.

Berberine or the next-best alternative for inflammation?

See the compare block above for the head-to-head with the most-cited alternative. Grade + certainty differences matter more than any single trial.

Related

What this is — and is not

Evidence description
Meta-analysis of 5 RCTs: berberine supplementation significantly decreased serum C-reactive protein versus control, with no significant heterogeneity between studies. The authors note patients with cardiovascular disease and diabetes may be the groups most likely to benefit; larger confirmatory trials are still needed.
Substrate's interpretation
The current reviewed record assigns Grade B at moderate certainty. A domain-by-domain rationale is shown only when recorded.
Discuss with a clinician
If you're on medication or have a condition that changes the calculus, bring the interaction & population blocks above to your pharmacist or prescriber before deciding.
Individualized medical advice
Not provided here or on any Substrate surface (API, agent tool, embed) — see YMYL policy.

Cite this page

Citation is encouraged. The proposed reuse license is CC-BY-4.0; status: pending-governance-ratification.

Plain-text citation
Substrate. Does Berberine help inflammation? (Grade B). https://evidencebased.info/interventions/berberine/inflammation. Updated 2026-07-16.
BibTeX
@misc{substrate_erberineinflammation,
  author = {Substrate editorial},
  title  = {Does Berberine help inflammation?},
  year   = {2026},
  url    = {https://evidencebased.info/interventions/berberine/inflammation},
  note   = {Grade B, evidencebased.info}
}

Found something wrong on this page? Report an error →

Current source-reported research

Membership uses admitted intervention and measured-outcome associations for this exact question. Different populations, preparations, comparators and timepoints remain separate. No pooling or update to the synthesis is asserted.